Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump
Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 billion adult "almost-pumpers" diabetes market with user-friendly, affordable patch pumps, today announced Institutional Review Board ("IRB") approval to conduct an in-house study of its next-generation Pivot™ insulin delivery system using insulin on people with diabetes (the "Study"). Pursuant to U.S....
Read more









